NEUROONE MEDICAL TECHNOLOGIES Corp Balance Sheet
NMTC|10 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 10 fiscal years. All figures from audited SEC 10-K filings.
NEUROONE MEDICAL TECHNOLOGIES Corp had $11M in total assets and $822,013 in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -2.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2016 | FY2015 | FY2014 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6.6M | $1.5M | $5.3M | $8.2M | $4.0M | - | - | - | - | - |
| Accounts Receivable | $1.3M | $176.6K | - | $33.2K | $48.3K | - | - | - | - | - |
| Inventory | $2.2M | $2.6M | $1.7M | $704.5K | $98.3K | - | - | - | - | - |
| Current Assets | $10.2M | $4.6M | $7.3M | $12.2M | $4.2M | - | $1.8K | $205 | $1.1K | $13.9K |
| PP&E (Net) | $259.2K | $416.8K | $525.8K | $353.6K | $166.0K | - | - | - | - | - |
| Total Assets | $10.8M | $5.4M | $8.1M | $12.8M | $4.8M | $4.3K | $1.8K | $205 | $1.1K | $13.9K |
| Current Liabilities | $2.3M | $2.2M | $1.8M | $3.1M | $2.4M | $117.9K | $83.3K | $35.6K | $18.4K | $4.6K |
| Shareholders' Equity | $822.0K | $6.2M | $9.6M | $6.6M | -$1.2M | -$113.7K | -$35.4K | -$30.3K | -$3.3K | -$4.3K |